This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Anderson, I.M. Articles by Tomenson, B.M. Search for Related Content PubMed Articles by Anderson, I.M. Articles by Tomenson, B.M. Social Bookmarking                         What's this?

The efficacy of selective serotonin re-uptake inhibitors in depression: a meta-analysis of studies against tricyclic antidepressants

B.M. Tomenson

University of Manchester Department of Psychiatry, Rawnsley Building, Manchester Royal Infirmary, Oxford Road, Manchester M13 9WL, UK

A meta-analysis of the efficacy of five selective serotonin re-uptake inhibitors (SSRIs) against non-selective and noradrenergic re-uptake inhibitors (mainly tricyclic antidepressants, TCAs) is presented. Fifty five double- blind studies were identified after excluding those multiply reported or with methodological problems likely to bias the outcome in favour of SSRIs. Standardised effect sizes and 95% confidence intervals were calculated based on the difference in the reduction in mean Hamilton depression rating scale (HDRS) scores for the two antidepressants. For studies not reporting standard deviations, the pooled variance from complete studies was used and a variance-weighted mean effect size calculated. There were no differences in efficacy between SSRIs and comparator antidepressants for SSRIs taken together or individually. If studies were classified into high and low depression scores based on a median split of initial HDRS scores, there was a slight advantage to TCAs in the high HDRS group. In addition, SSRIs were slightly less effective than TCAs in in-patients and against combined serotonin and noradrenaline re-uptake inhibitors (clomipramine and amitriptyline). These findings were accounted for by a clinically significant lower efficacy of paroxetine in these subgroups. In contrast, SSRIs as a group were marginally more effective than noradrenergic antidepressants, a finding accounted for by two studies with sertraline. Fluvoxamine was the only SSRI to have been tested adequately in in-patients, where it displayed equal efficacy to TCAs. This meta-analysis confirms that SSRIs and TCAs are in general equally effective, but suggests that paroxetine's efficacy in in-patients and against clomipramine and amitriptyline is not proven.

Key Words: meta-analysis • selective serotonin re-uptake inhibitors • tricyclic antidepressants • efficacy • depression; treatment

Journal of Psychopharmacology, Vol. 8, No. 4, 238-249 (1994)
DOI: 10.1177/026988119400800407


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				L. Trick, N. Stanley, U. Rigney, and I. Hindmarch A Double-Blind, Randomized, 26-Week Study Comparing the Cognitive and Psychomotor Effects and Efficacy of 75 mg (37.5 mg b.i.d.) Venlafaxine and 75 mg (25 mg Mane, 50 mg Nocte) Dothiepin in Elderly Patients with Moderate Major Depression Being Treated in General Practice J Psychopharmacol, June 1, 2004; 18(2): 205 - 214. [Abstract] [PDF]

				R. L. Dunn, J. M. Donoghue, R. J. Ozminkowski, D. Stephenson, and T. R. Hylan Longitudinal patterns of antidepressant prescribing in primary care in the UK: comparison with treatment guidelines J Psychopharmacol, March 1, 1999; 13(2): 136 - 143. [Abstract] [PDF]

				A.J. Harmar, A.D. Ogilvie, S. Battersby, C.A.D. Smith, D.H.R. Blackwood, W.J. Muir, G. Fink, and G.M. Goodwin The Serotonin Transporter Gene and Affective Disorder Cold Spring Harb Symp Quant Biol, January 1, 1996; 61(0): 791 - 795. [Abstract] [PDF]